Statistics from Altmetric.com
Attention deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric disorders of childhood, affecting 3–7% of school-age children.1 Stimulant medication is an effective treatment for childhood ADHD and is well established as a first-line treatment in most clinical settings. However, controversy remains about the potential for stimulant medications to increase susceptibility to later substance use disorders (SUD), possibly by sensitisation of dopamine receptors and altering dopamine neurotransmission associated with addiction.2 ,3 The only previous meta-analysis was published 10 years ago and concluded that children who were treated with stimulant medication for ADHD were significantly less likely to develop SUD.3 The meta-analysis by Humphreys and colleagues represents an …
Correction notice This article has been corrected since it was published Online First. The author surname ‘Humphries’ has been corrected to ‘Humphreys’ throughout the article.
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.